Because of their unique capacity to cross-present Ags to CD8 + T cells, mouse lymphoid tissue-resident CD8 + dendritic cells (DCs) and their migratory counterparts are critical for priming antiviral T cell responses. High expression of the dsRNA sensor TLR3 is a distinctive feature of these cross-presenting DC subsets. TLR3 engagement in CD8 + DCs promotes cross-presentation and the acquisition of effector functions required for driving antiviral T cell responses. In this study, we performed a comprehensive analysis of the TLR3-induced antiviral program and cell-autonomous immunity in CD8 + DC lines and primary CD8 + DCs. We found that TLR3-ligand polyinosinic-polycytidylic acid and human rhinovirus infection induced a potent antiviral protection against Sendai and vesicular stomatitis virus in a TLR3 and type I IFN receptor-dependent manner. Polyinosinic-polycytidylic acid-induced antiviral genes were identified by mass spectrometry-based proteomics and transcriptomics in the CD8 + DC line.
D endritic cells (DCs) comprise distinct subtypes differing in their phenotype, function, localization, and migratory properties (1) (2) (3) (4) . Four main cell types are generally categorized as DCs: plasmacytoid DCs (pDCs), Langerhans cells, monocyte-derived DCs (MoDCs), and classical or conventional DCs (cDCs) (1, 4) . Major mouse cDC subtypes include CD8 + and CD8
2 DCs in lymphoid tissues, and CD103 + and CD11b + DCs in nonlymphoid organs (1, 5) . CD8 + DCs, and the functionally and developmentally related CD103 + DCs, are specialized for inducing antiviral cytotoxic CTL responses because they are particularly efficient at crosspresenting peptides derived from exogenous Ags in the context of MHC class I molecules (1, (6) (7) (8) (9) . Ags derived from infected tissues are believed to be transferred to CD8 + DCs by lymphatic drainage or migratory DCs (3) . Activated CD8 + DCs secrete cytokines, such as IL-12, IL-6, and type I and III IFNs, promoting immune responses against viruses and parasitic protozoans (10) (11) (12) .
DCs induce appropriately tailored immune responses by detecting, integrating, and responding to pathogen-associated molecular patterns and host-derived signals, including dangerassociate molecular patterns and cytokines. Signaling through the receptors of these signals triggers and/or promotes the maturation (activation) of DCs (3) . In addition to their key effects on maturation, these signals can modify other features of DCs. For example, CD103 + DCs can acquire protection against viral infection in vivo via type I IFNs (I-IFN) (13, 14) . Pathogenassociated molecular patterns are detected by pattern recognition receptors, including transmembrane TLRs, intracellular receptors, such as RIG-I-like receptors, and NOD-like receptors (15, 16) .
Mouse CD8 + and CD103 + DCs express the highest levels of TLR3 (5, 15) , a dsRNA receptor that detects viral genomes or replication intermediates in endolysosomal compartments (17) . TLR3 signals via the adaptor protein TRIF and activates signalregulated transcription factors, of which the best characterized are NF-kB, AP-1, and IRF3 (16, 18) . Studies with mouse bone marrowderived DCs (BMDCs) have shown that TLR-induced regulatory programs also involve numerous other transcription factors and coregulators controlling complex transcriptional responses (19, 20) . Activation of cDCs by viral dsRNA or synthetic dsRNAanalogs, such as polyinosinic-polycytidylic acid (pIC), triggers maturation, promotes cross-priming, confers antiviral protection, and induces production of I-IFN and type III IFNs (III-IFNs), chemokines (such as CXCL10 and CCL5), and inflammatory cytokines (such as IL-6 and TNF-a) (10, 11, 18, 21, 22) .
TLR3-activated antiviral genes can be induced by two mechanisms, directly and indirectly via I-IFN production (23) . Certain IFN-stimulated genes (ISGs) can interfere with diverse steps in viral infections, including viral entry, uncoating, replication, assembly, budding, and release (24, 25) . TLR3 agonist-induced expression of I-IFN and antiviral effectors has been implicated in the establishment of a cell-autonomous antiviral state in diverse cell types, such as fibroblasts, hepatocytes, mouse bone marrowderived macrophages, BMDCs, and human MoDCs (21, 23, (26) (27) (28) (29) (30) , although in many studies the involvement of TLR3 was not demonstrated and/or that of intracellular dsRNA sensors was not excluded.
Despite the pivotal role of CD8 + DCs in driving antiviral immunity (31) and their distinctive property of high TLR3 expression (5, 15, 32) 
Materials and Methods

Cells
Wild-type (WT) (MuTu1940), Tlr3 2/2 , and Ifnar1 2/2 CD8 + DC lines were established and cultured as described previously (33, 34) . Splenic CD8 + DCs were isolated from Flt3L-transgenic mice (35) or WT C57BL/6J mice using CD8 + DC purification kit (130-091-169; Miltenyi Biotec). DCs were stimulated with 5 mg/ml pIC [poly(I:C) HMW, tlrl-pic; Invivogen], 10 3 U/ml IFN-b (12401-1; PBL Laboratories), 10 4 U/ml IFN-a (130-093-131; Miltenyi Biotec), 10 ng/ml IFN-g (34-8311-85; eBioscience), 100 ng/ml IFNl3 (12820-1; PBL Laboratories), and 100 ng/ml LPS (ALX-581-009; Alexis-Enzo). The following Abs were used to detect DC and maturation markers: anti-CD80 (16-10A1; BD Biosciences), anti-CD8a (53-6.7; eBioscience), and anti-CD11c (N418; eBioscience). Dependence of pICinduced expression on de novo protein synthesis was assessed by pretreatment for 0.5 h with 20 mg/ml cycloheximide (CHX; Sigma-Aldrich). Animal husbandry and isolation of splenic CD8 + DCs from Flt3L-transgenic mice were approved by and performed in accordance with guidelines from the Animal Research Committee of the University of Lausanne and University of Geneva.
Viral infections
Sendai virus (SeV)-RFP (tdTomato) and SeV-GFP were generated by D.G. (36) . Vesicular stomatitis virus (VSV) and a clinical human rhinovirus (HRV) strain (HRV14) were gifts from J. Perrault and C. Tapparel. RFP (tdTomato) or GFP expression in infected cells was assessed by flow cytometry or microscopy. Cell viability was assessed by phase-contrast microscopy or flow cytometry using 7-aminoactinomycin D (7AAD) staining. Infection of the DC cell line. SeV expressing red fluorescent protein (SeV-RFP)-or VSV-infected cells were not pretreated, pretreated for 18 h with 5 mg/ml pIC or I-IFNs (10 3 U/ml IFN-b or 10 4 U/ml IFN-a), or preinfected for 18 h with HRV. Uninfected cells were used as negative controls. The capacity of pIC to induce an antiviral state was also tested by adding it at various time points ranging from 18 h before to 16 h post SeV-RFP infection. The antiviral state was induced most efficiently when pIC was added between 6 and 18 h before infection. pIC was less efficient or ineffective when added together with or after SeV infection. 
Transcriptomics
Total RNA was isolated using RNeasy kits (Qiagen). Processing, labeling, hybridization to Affymetrix GeneChip Mouse 1.0 ST Arrays, and scanning were conducted at the Genomics Platform (University of Geneva) according to the manufacturer's instructions. Cel image files were imported to GeneSpring 12.6.1 software. Normalization was performed using robust multiarray average summarization algorithm. Significantly regulated genes were identified using a 2-fold cutoff and moderated t test with the Benjamini-Hochberg procedure for multiple test correction (adjusted p , 0.05). Microarray data were deposited in Gene Expression Omnibus (http://www.ncbi.nlm.nih.gov/geo/) under accession number GSE57512.
Liquid chromatography-mass spectrometry-based quantitative proteomics
Cells were lysed in 2% SDS, Tris HCl pH 7.6. Proteins were denatured by boiling and sonication in the presence of dithiothreitol. Cysteine reduction was followed by alkylation with iodoacetamide. Proteins were precipitated with 80% acetone for 16 h, resolubilized in 6 M urea/2 M thiourea, digested for 3 h with 1 mg LysC/50 mg protein (Wako), diluted 1:4, and digested for 16 h at room temperature with 1 mg trypsin/50 mg protein (Promega). Peptides were desalted on reversed-phase C18 material and eluted with 80% acetonitrile in 0.5% acetic acid. The volume was reduced in a SpeedVac and peptides were acidified with 2% acetonitrile, 0.1% trifluoroacetic acid in 0.1% formic acid.
A nanoflow UHPLC instrument (Easy nLC; Thermo Fisher Scientific) was coupled online to a Q Exactive mass spectrometer (Thermo Fisher Scientific) with a nanoelectrospray ion source (Thermo Fisher Scientific). Chromatography columns were packed with ReproSil-Pur C18-AQ 1.8 mm resin (Dr. Maisch GmbH). Two-microgram peptides were separated with a gradient of 5-60% buffer B (80% acetonitrile in 0.1% formic acid) at a flow rate of 200 nl/min over 240 min using 50-cm analytical columns. Mass spectrometry (MS) data were acquired with a data-dependent Top10 acquisition method dynamically choosing the most abundant precursor ions from the survey scan (300-1650 Th) for higher-energy collisional dissociation fragmentation. Survey scans were acquired at a resolution of 70,000 at m/z 200. Unassigned precursor ion charge states as well as singly charged species were rejected. The isolation window was set to 2 Th and normalized collision energies to 25. The maximum ion injection times for the MS1 scan and the MS2 scans were 20 and 60 ms with ion target values of 3E6 and 1e6, respectively. Selected sequenced ions were dynamically excluded for 40 s. Data were acquired using Xcalibur software.
Mass spectra were analyzed with MaxQuant software version 1.2.6.20 using the Andromeda search engine. The allowed mass deviation was set to 6 ppm for monoisotopic precursor ions and 0.5 Da for MS/MS peaks. Enzyme specificity was set to trypsin, defined as C-terminal to arginine and lysine including proline, and a maximum of three missed cleavages were allowed. Carbamidomethylcysteine was set as a fixed modification, N-terminal acetylation and methionine oxidation as variable modifications. The data were searched against the mouse Uniprot sequence database (Uniprot version 2012-02-25) supplemented with frequently observed contaminants and concatenated with the reversed versions of all sequences. The required false-positive rate was set to 1% at the peptide and 1% at the protein level, and the minimum required peptide length was set to 7 aa. Protein identification required at least one unique or razor peptide per protein group. Quantification in MaxQuant was performed using label-free quantification algorithm with fast label-free quantification and match between runs enabled. A peptide library derived by digestion of lysates from MuTu cells activated through different cellular receptors was used for matching.
Contaminants, reverse identification, and proteins only identified by site were excluded from further data analysis. Missing values were imputed by random sampling from a generated narrow normal distribution around the detection limit for proteins. Imputed data were imported to GeneSpring 12.6.1 software. Normalization was performed using robust multiarray average summarization algorithm. Significantly upregulated proteins were identified using a 2-fold cutoff and moderated t test with the BenjaminiHochberg procedure for multiple test correction (adjusted p , 0.05).
Nanostring nCounter analysis
CodeSets for Nanostring nCounter analysis (37) were constructed for housekeeping (control) genes, and for genes encoding antiviral ISGs, cytokines, and maturation markers. Total RNA was purified using peqGOLD TriFast reagent (PEQLAB). A total of 100 ng RNA was hybridized with the CodeSets and loaded into the nCounter prep station, followed by quantification using the nCounter Digital Analyzer at the Genomics Platform (University of Geneva).
Results
CD8
+ DC line represents a reliable model for primary CD8
+ DCs
We previously reported that our mouse CD8 + DC lines retained all major phenotypic and functional features of their in vivo counterparts, including characteristic cell-surface marker expression, responsiveness to TLR stimuli, patterns of cytokine and chemokine production, cross-presentation capacity, and T cell-stimulatory properties (33) . This was further confirmed by studying the expression of 257 genes identified as cDCs, pDCs, CD8
2 DCs, CD8 + DCs, and CD103 + signature genes by the Immunological Genome Project (ImmGen) (5) . Expression of these genes was remarkably similar between the CD8 + DC line, CD8 + DCs, and tissue CD103 + DCs (Supplemental Fig. 1 ). In principal component analysis, the CD8 + DC line clustered with these primary DC subsets (Fig. 1A) . Genes encoding nucleic acid-sensing TLRs (Tlr3, Tlr7, Tlr9 and Tlr13) were also expressed similarly between the CD8 + DC line, CD8 + DCs, and CD103 + DCs (Fig. 1B) . Tlr3 was notably expressed strongly in the CD8 + DC line (5) (Supplemental Fig. 1 ). Finally, Nanostring nCounter analyses indicated that selected genes were induced comparably by pIC in the CD8 + DC line and splenic CD8 + DCs (Fig. 1C) .
TLR3-dependent induction of an antiviral state in CD8 + DCs
Establishment of a pIC-induced antiviral state in the CD8 + DC line was examined by assessing protection against SeV and VSV (Fig. 2) . Such negative ssRNA viruses are not detected by TLR3 because their replication does not produce detectable amounts of dsRNA (38) . They consequently do not induce maturation of CD8 + DCs, which express low levels of cytoplasmic RIG-I-like receptors, the major sensors for negative ssRNA viruses in cDCs (32) . An assay based on infection with SeV-RFP was used ( Fig. 2A) . Examination of CD80 expression confirmed that SeV-RFP did not induce maturation of the CD8 + DC line (Fig. 2B) . Quantification of RFP demonstrated that pretreatment of the CD8 + DC line with pIC blocked SeV-RFP replication similarly to IFN-a (Fig. 2C, 2E ). For VSV, which is highly cytopathic, cell viability was evaluated by 7AAD staining. Pretreatment of the CD8 + DC line with pIC abrogated the cytopathic effect of VSV to the same extent as IFN-a (Fig. 2D) . Examination of cell morphology confirmed that VSV-induced cell death was inhibited by pIC or IFN-a pretreatment (Fig. 2D) . We stimulated the DC line with pIC at various time points (between 218 h and +16 h) relative to infection with SeV-RFP. The most efficient time frame for establishing the antiviral state by pIC was between 6 and 18 h of pretreatment. pIC was less efficient or ineffective when it was administrated together with or after SeV infection (Supplemental Fig. 2B ). We next tested whether a viral infection accompanied by the production of dsRNA can induce an antiviral state in the CD8 + DC line. The replication of positive ssRNA viruses proceeds via dsRNA intermediates constituting natural TLR3 ligands (11, 17, 38) . As observed for pIC and IFN-a pretreatment, infection of the CD8 + DC line with HRV induced an antiviral state that impaired SeV-RFP replication (Fig. 2E ). This correlated with the induction + DC line with primary DC subsets using ImmGen microarray data for 257 differentially expressed signature genes. Our microarray data were used for the CD8 + DC line. The CD8 + DC line (red dots, three measurements) clusters with lymph node-resident CD8 + (orange) and tissue-resident CD103 + (yellow) DCs. Notably, other CD103 + DCs isolated from lymphoid tissues cluster separately. (B) Tlr3, Tlr7, Tlr9, and Tlr13 expression is compared between the CD8 + DC line and the indicated DC subsets. (C) mRNA expression for the indicated genes was quantified by Nanostring nCounter in the CD8 + DC line and splenic CD8 + DCs treated for 0 and 6 h with pIC. Data expressed in arbitrary units (AU) were normalized relative to Eef1a1, Ppia, Rpl13a, Rplp0, and Sdha. The mean and SD derived from three independent experiments are shown. of primary (Ifit1, Isg15) and secondary (Irf7, Mx1) TLR3-response genes (23) (Fig. 2F) .
A Tlr3-deficient CD8 + DC line was used to determine whether induction of the antiviral state requires TLR3 engagement. Both pIC pretreatment and HRV infection failed to inhibit SeV-RFP replication in Tlr3 2/2 CD8 + DC cells, whereas the antiviral state was readily conferred by IFN-a (Fig. 2E) .
Two approaches were used to evaluate the establishment of a pIC-induced antiviral state in primary CD8 + DCs. First, splenic CD8 + DCs isolated from WT mice were pretreated in vitro with pIC before infection with SeV-GFP (Fig. 2G) . Second, SeV-GFP infections were performed with splenic CD8 + DCs isolated from WT mice that had been pretreated with pIC in vivo (Fig. 2H) . In both experimental setups, pIC significantly reduced the percentage of infected GFP + CD8 + DCs. These results indicated that pIC can induce cell-intrinsic antiviral protection in both the CD8 + DC cell line and primary splenic CD8 + DCs.
I-IFNs play a crucial role in establishment of the antiviral state in CD8 + DCs pIC can induce I-IFN and III-IFN production by CD8 + DCs (10, 11, 22, 39) . Neutralizing Abs against I-IFN can inhibit the establishment of a pIC-induced antiviral state in human MoDCs (28) . In mouse bone marrow-derived macrophages, some antiviral ISGs such as Irf7 and Mx1 are induced indirectly by TLR4 or TLR3 ligands via autocrine I-IFN stimulation (23) . These findings prompted us to study the role of IFN signaling in establishment of the TLR3-induced antiviral state in CD8 + DCs. We exploited a CD8 + DC line lacking the gene (Ifnar1) encoding a subunit of the I-IFN receptor. pIC-and I-IFN-induced Irf7 and Mx1 expression was abolished in Ifnar1 2/2 cells (Fig. 3A) . Conversely, pIC-induced expression of other TLR3-response genes, such as Ccl5, Cd40, and Ebi3, was not affected in Ifnar1 2/2 cells (data not shown). As expected, IFN-a stimulation could not abrogate SeV-RFP replication in the Ifnar1 2/2 cells (Fig. 3B ). pIC and HRV likewise failed to inhibit SeV-RFP replication in Ifnar1 2/2 cells, demonstrating that I-IFN is a key mediator of the TLR3-induced antiviral state (Fig. 3B) . We next examined the expression of IFNs and their receptors in CD8 + DCs to evaluate their contributions to induction of the antiviral state. Ifnb1, Ifnl2 (also known as Il28a), and Ifnl3 (also known as Il28b) mRNAs were induced in the CD8 + DC line within 2 h after pIC stimulation (Fig. 3C) . IFN-b secretion was also induced by pIC and exposure to HRV-infected apoptotic cells, but not by LPS, for which the cognate pattern recognition receptor (TLR4) is not expressed by CD8 + DCs (Fig. 3D) . Genes encoding subunits of the I-IFN (Ifnar1, Ifnar2) and II-IFN (Ifngr1, Ifngr2) receptors were expressed in the CD8 + DC line. In contrast, of the 
TLR3-INDUCED ANTIVIRAL STATE IN CD8 + DCs
genes encoding the III-IFN receptor subunits (Ifnlr1 and Il10rb), only Il10rb was expressed (Fig. 3E) . Analysis of ImmGen microarray data indicated that primary CD8 + DCs exhibit similar patterns of IFNR subunit expression, including low Ifnlr1 expression (Supplemental Fig. 2A ). In accordance with the pattern of IFNR expression in CD8 + DCs, and known cytokine signaling pathways, Ifit1, Isg15, Irf7, and Mx1 were induced in the CD8 + DC line and splenic CD8 + DCs by I-IFNs (IFN-a and IFN-b) , but not IFN-g or IFN-l3 (Fig. 3F) . These results indicate that only I-IFN contributes to establishment of the pIC-induced antiviral state in CD8 + DCs, although they produce both IFN-b and III-IFNs.
Identification of pIC-induced antiviral genes in CD8 + DCs
To investigate pIC-induced antiviral genes in CD8 + DCs, we analyzed the transcriptome and proteome of the CD8 + DC line stimulated for various times with pIC, by means of DNA microarray experiments and quantitative MS, respectively (Fig. 4A) . pIC-regulated expression was examined for 148 antiviral genes and ISGs (extracted from Refs. 24 and 25 and/or annotated as such in Uniprot). For 47 of these genes, mRNA and/or protein expression were upregulated by pIC at one or more time points (Supplemental Fig. 3 ). For most (30 genes), upregulation was evident at both the transcript and the protein level. For a smaller portion (15 genes) of induced mRNAs, the corresponding proteins were not detectable or upregulated (Supplemental Fig. 3 ). Finally, in two cases, only MS detected upregulation. Relatively few mRNAs exhibited robust induction after 2 h, whereas most peaked at 6 h (Fig. 4B, 4C ). Most proteins peaked at 18 h (Fig. 4B, 4C) . Finally, antiviral proteins were induced significantly more strongly than other upregulated proteins (Fig. 4D) . Six of the top 10 most strongly upregulated proteins were encoded by antiviral ISGs (Ifit1, Ifit2, Gbp2, Oas1a, Ifit3, and Isg20; Supplemental Fig. 3C ).
Based on fold induction (Supplemental Fig. 3 ) and biological relevance, 18 antiviral genes (Table I) were selected for Nanostring nCounter (37) analysis. Induction by pIC was confirmed for all 18 mRNAs in both the CD8 + DC line and the primary splenic CD8 + DCs (Fig. 4C) . Fold inductions quantified by Nanostring nCounter were markedly stronger than when estimated by microarray analysis (data not shown). Induction was strictly TLR3 dependent because it was abolished in the Tlr3 2/2 CD8 + DC line (Fig. 4E ). TLR3 dependence was further confirmed by the finding that polyadenylic-polyuridylic acid, a more TLR3-specific ligand, was as efficient an inducer as pIC (data not shown). Finally, all 18 genes were inducible by both pIC and IFN-a (Fig. 4F) .
Identification of primary and secondary TLR3-response genes in CD8 + DCs
Investigations on TLR-induced gene expression have shown that antiviral genes and ISGs can be classified into primary and secondary response genes (23) (Figs. 5A, 6 ). Primary response genes are induced in the absence of de novo protein synthesis, whereas secondary response ISGs are induced indirectly via production of the primary response gene I-IFN. Primary response genes are typically induced more rapidly by pIC than secondary response ISGs. Furthermore, the latter should be induced more rapidly by IFN-b than pIC. These predictions were validated in the CD8 + DC line for prototypical primary response genes (Ifit1 and Isg15), primary response proinflammatory cytokine genes (Il12b and Il1b), and secondary response ISGs (Irf7 and Mx1) (Fig. 5B) . We therefore categorized ISGs induced in the CD8 + DC line on the basis of two parameters, kinetics of pIC-induced expression (Fig. 5C ) and relative induction efficiency by IFN-b versus pIC at an early time point (Fig. 5D) . The two approaches correlated remarkably well: pIC-dominant genes exhibited rapid pIC induction, whereas IFN-b-dominant ISGs exhibited delayed pIC induction (Fig. 5E) .
To further classify pIC-induced antiviral genes into primary and secondary response genes, we assessed their dependence on de novo protein synthesis using the protein-synthesis inhibitor CHX (Fig. 5F ). pIC-dominant genes (including Ifit1 and Isg15) were mainly CHX insensitive, confirming that they are primary response genes. Two pIC-dominant genes (Rsad2 and Ifit2) exhibited partial CHX sensitivity, suggesting that they are primary response genes for which induction is amplified by autocrine IFN-b stimulation. Most IFN-b-dominant ISGs (including Irf7 and Mx1) exhibited CHX-sensitive pIC induction, suggesting that they are secondary response genes. Three genes (Oasl2, Isg20, and Ddx58) were IFN-b dominant but exhibited CHX-insensitive pIC induction, suggesting that they are controlled by nonredundant TLR3 and IFN-b-regulated pathways. For one gene (Trim30d), CHX insensitivity could not be established conclusively because it was induced only slightly by pIC after 2 h. 
Discussion
We found that TLR3 engagement can establish a potent cellautonomous antiviral state in CD8 + DCs. It is likely that a similar antiviral program is triggered by TLR3 engagement in migratory CD103
+ DCs, which share with CD8 + DCs the unique property of high TLR3 expression. To dissect the antiviral program induced by TLR3 stimulation in CD8 + DCs, we performed comprehensive mRNA and protein expression profiling experiments. To our knowledge, no such combined transcriptomic/proteomic analyses have been performed in either CD8 + or CD103 + DCs. Such integrated studies have been difficult to perform with primary ex vivo DC subsets. Existing transcriptomic or proteomic analyses of TLR-induced DC activation have mainly exploited mouse GM-CSF-generated BMDCs. However, GM-CSF-generated BMDCs represent monocyte-derived inflammatory DCs, in which TLR3 is lowly expressed, and the recognition of long form of pIC is mediated in large part by cytoplasmic RNA helicase MDA5 (22, 40, 41) . The availability of a cell line exhibiting all (42, 43) , I-IFNs are known to contribute to diverse DC properties, including maturation, cross-presentation, and activation of antitumor and antiviral responses (13, 14, 42, (44) (45) (46) . I-IFN production is also necessary and sufficient for pIC-induced apoptosis of CD8 + DCs (39) . Our results show that the induction of a cellautonomous antiviral state is a key function of I-IFN production by CD8 + DCs (Fig. 6) . III-IFNs cannot replace IFN-b for establishing the TLR3-induced antiviral state because the CD8 + cells lack a functional III-IFNR. This is consistent with the fact that IFN-lR1 expression is restricted to certain cell types, and that most leukocytes do not respond to IFNl even at high concentrations (47) .
Expression profiling studies have shown that I-IFN can induce up to 1000 ISGs, of which 200-500 are typical of many cell types (25) . Certain ISGs (estimated at a few dozen) have broad or virusrestricted antiviral effector functions (25, 48) . We classified pICinduced antiviral genes in CD8 + DCs into primary response genes activated directly by TLR3-signaling and secondary response ISGs for which indirect activation via autocrine I-IFN signaling makes a major contribution. Only four ISGs (Ifit1, Ifih1, Oasl1, and Isg15) exhibited features expected for primary TLR3-response genes, whereas eight (Gbp2, Mx1, Zbp1, Ifit3, Bts2, Oas1a, Irf7, and Oas3) exhibited features typical of secondary response genes. The latter are likely to make essential contributions to protection against SeV and VSV in our CD8 + DC system, because the TLR3-induced antiviral effect is strictly dependent on autocrine IFN-b signaling. In contrast, genes for which direct induction by TLR3 signaling is the dominant mechanism are not sufficient for conferring protection against SeV or VSV. They could, however, collaborate with secondary response ISGs or play key roles in protection against other viruses.
The establishment of a TLR3-induced antiviral state in CD8 + DCs presumably preserves their capacity to prime antiviral T cell responses despite potentially destructive viral loads in secondary lymphoid tissues. The same mechanism could preserve the ability of migratory CD103 + DCs to transport Ags to secondary lymphoid organs through infected tissues and lymphatics containing circulating virus. Furthermore, paracrine stimulation by I-IFN produced by activated CD8 + DCs may contribute to establishing an antiviral state in other cells present in secondary lymphoid tissues, including macrophages, other DC subtypes, T cells, B cells, and nonhematopoietic cells. The mechanism we describe in this article is therefore likely to shield immune responses from the nefarious consequences of viral infection. It could be particularly relevant for viruses detected mainly by TLR3, such as positive ssRNA viruses, which may not trigger I-IFN production by pDCs or other cDC subsets lacking TLR3.
